Page last updated: 2024-09-05
clorazepate dipotassium and Myocardial Infarction
clorazepate dipotassium has been researched along with Myocardial Infarction in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Papadimitriou, GN; Psarros, C; Sakkas, P; Soldatos, CR; Theleritis, CG | 1 |
| Wheatley, D | 1 |
Other Studies
2 other study(ies) available for clorazepate dipotassium and Myocardial Infarction
| Article | Year |
|---|---|
Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Citalopram; Clorazepate Dipotassium; Cyclohexanols; Depressive Disorder; Humans; Male; Middle Aged; Myocardial Infarction; Panic Disorder; Psychiatric Status Rating Scales; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride | 2006 |
Clorazepate in the management of coronary disease.
Topics: Anti-Anxiety Agents; Anxiety; Clorazepate Dipotassium; Humans; Myocardial Infarction | 1979 |